CA-VELODYNE-LIDAR,-INC.
28.8.2020 14:02:10 CEST | Business Wire | Press release
Velodyne Lidar, Inc. today announced it has joined the Intelligent Transportation Society of America (ITS America) to promote the benefits of autonomous vehicles and intelligent transportation infrastructure. Velodyne is the first lidar technology company to become part of this influential group. ITS America members are at the forefront of driving progress in autonomous vehicles and smart city solutions to help save lives, improve mobility and promote sustainability.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200828005057/en/
Velodyne’s lidar sensors can be used in a variety of Intelligent Transportation Systems to measure and monitor conditions in areas such as pedestrian safety, vehicle traffic and parking space management, and more. They can collect reliable, detailed traffic data about road users, including vehicles, pedestrians and bicyclists, while preserving anonymity. Velodyne’s lidar sensors do not identify individuals’ facial characteristics, a growing requirement for civic applications. In addition to transportation systems, Velodyne’s lidar sensors have a strong presence in autonomous vehicles and advanced driver assistance systems (ADAS).
Velodyne has a long-standing commitment to fostering understanding of the safety and mobility benefits of autonomous vehicles and intelligent infrastructure to consumer, business, government, public safety and community audiences. These efforts include Velodyne’s World Safety Summit on Autonomous Technology . The event has sparked collaborative work to advance solutions for rolling out autonomy and ADAS with the goal of improving safety on the roadways. Velodyne also partners with Mothers Against Drunk Driving (MADD) on public education about improving safety on roadways.
Velodyne’s lidar sensors are used in a rich ecosystem of customers and applications, which is highlighted in the Automated with Velodyne program. Partners in the program provide solutions for smart city, infrastructure, autonomous vehicles and more. Within the program, Velodyne is working to advance research in transportation infrastructure, partnering with University of Nevada, Reno . The university’s Nevada Center for Applied Research, working in conjunction with the Nevada DOT and Nevada Governor’s Office of Economic Development , is using Velodyne’s sensors in its Intelligent Mobility initiative. Velodyne is also partnering with automotive OEMs, and robotaxi and autonomous shuttle companies to enable safe and efficient transportation options for cities. For instance, Voyage has built the technology and services to bring autonomous transportation to those who need it, beginning in retirement communities.
“Lidar is a foundational technology that will help drive intelligent mobility in smart city applications and in vehicles on our roadways,” said Shailen Bhatt, President & CEO, ITS America. “Velodyne has demonstrated a strong commitment and great skills in advancing public knowledge about lidar and how autonomous technology can greatly improve transportation. We welcome their contributions in helping ITS America promote intelligent transportation technologies.”
“Velodyne Lidar is strongly aligned with the ITS America mission to improve mobility, advance safety on the roadways, and increase efficiency in our communities,” said Sally Frykman, VP of Communications, Velodyne Lidar. “We envision companies and government organizations will use Velodyne’s lidar sensors to enable a new generation of smart infrastructure through data collection and the deployment of autonomous vehicles.
About Velodyne Lidar
Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized VELARRAY™, and the groundbreaking software for driver assistance, Vella™.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200828005057/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
